rs767203075
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PS1_ModeratePM2PP3
The NM_005670.4(EPM2A):c.272G>C(p.Arg91Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000144 in 1,385,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely pathogenic in UniProt.
Frequency
Consequence
NM_005670.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000144 AC: 2AN: 1385796Hom.: 0 Cov.: 30 AF XY: 0.00000146 AC XY: 1AN XY: 685908
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Lafora disease Pathogenic:1
The p.Arg91Pro variant in EPM2A has been reported in 2 individuals with Lafora disease (PMID: 15009235, 14722920, 16529633), and has been identified in 0.0002% (2/1073170) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. Of the 2 affected individuals, 1 was a homozygote, which increases the likelihood that the p.Arg91Pro variant is pathogenic (PMID: 15009235, 16529633). In vitro functional studies provide some evidence that the p.Arg91Pro variant may slightly impact protein function (PMID: 34755096). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. The p.Arg91Pro variant is located in a region of EPM2A that is essential to protein folding and stability, suggesting that this variant is in a functional domain and slightly supports pathogenicity (PMID: 34755096). The phenotype of an individual homozygous for this variant is highly specific for Lafora disease based on lafora bodies found on biopsy consistent with disease (PMID: 16529633). In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for autosomal recessive Lafora disease. ACMG/AMP Criteria applied: PP3, PM1_supporting, PM2_supporting, PM3_supporting, PS3_supporting, PP4_moderate (Richards 2015). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.